Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Subject
Description
Detection of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most reliable indicator of contagiousness.
Date
2020-12-01
Type
Citation
Aydillo, Teresa, Ana S. Gonzalez-Reiche, Sadaf Aslam, Adriana van de Guchte, Zenab Khan, Ajay Obla, Jayeeta Dutta, Harm van Bakel, Judith Aberg, Adolfo García-Sastre, Gunjan Shah, Tobias Hohl, Genovefa Papanicolaou, Miguel-Angel Perales, Kent Sepkowitz, N. Esther Babady, and Mini Kamboj. 2020. "Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer." New England Journal of Medicine.
Accessibility
Free online on NEJM.
Was this resource helpful?